advertisement
11.3.4 Betablocker (16)
Showing records 1 to 16
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker71440 Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs
Selen F
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 170-175
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Lerner SF
Journal of Ophthalmology 2017; 2017: 1917570
71233 Impact of Combination Glaucoma Therapies on β-Blocker Exposure
Xu K
Journal of Glaucoma 2017; 26: e107-e109
71359 The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Seibold LK; DeWitt PE
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 161-169
71233 Impact of Combination Glaucoma Therapies on β-Blocker Exposure
Campbell EL
Journal of Glaucoma 2017; 26: e107-e109
71440 Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs
Tekeli O
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 170-175
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Park KH
Journal of Ophthalmology 2017; 2017: 1917570
71440 Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs
Yanık Ö
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 170-175
71359 The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Kroehl ME
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 161-169
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Hubatsch DA
Journal of Ophthalmology 2017; 2017: 1917570
71233 Impact of Combination Glaucoma Therapies on β-Blocker Exposure
Gill SS
Journal of Glaucoma 2017; 26: e107-e109
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Erichev V
Journal of Ophthalmology 2017; 2017: 1917570
71233 Impact of Combination Glaucoma Therapies on β-Blocker Exposure
Nesdole R
Journal of Glaucoma 2017; 26: e107-e109
71359 The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Kahook MY
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 161-169
71233 Impact of Combination Glaucoma Therapies on β-Blocker Exposure
Campbell RJ
Journal of Glaucoma 2017; 26: e107-e109
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Paczka JA; Roberts TV
Journal of Ophthalmology 2017; 2017: 1917570
